Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.3850
-0.0077 (-1.96%)
May 14, 2025, 12:24 PM - Market open

Generation Bio Co. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-71.93-131.67-126.61-136.64-119.15-80.52
Upgrade
Depreciation & Amortization
4.764.935.265.134.533.43
Upgrade
Loss (Gain) From Sale of Assets
----0.24-
Upgrade
Asset Writedown & Restructuring Costs
0.260.260.045.81--
Upgrade
Loss (Gain) From Sale of Investments
-6.52-7.85-9.34-2.290.530.25
Upgrade
Stock-Based Compensation
12.6214.6124.3424.4517.868.41
Upgrade
Other Operating Activities
6.8162.590.030.04--
Upgrade
Change in Accounts Payable
0.5-0.391.09-1.391.76-1.44
Upgrade
Change in Unearned Revenue
-18.39-15.1241.6---
Upgrade
Change in Other Net Operating Assets
-13.33-15.9310.852.432.42-0.27
Upgrade
Operating Cash Flow
-85.23-88.56-52.75-102.45-91.82-70.14
Upgrade
Capital Expenditures
-0.73-2.4-7.4-8.8-5.96-5.52
Upgrade
Sale of Property, Plant & Equipment
0.230.2--0.11-
Upgrade
Investment in Securities
98.5496.73-2.3-183.71198.9-199.68
Upgrade
Investing Cash Flow
98.0494.53-9.7-192.52193.05-205.2
Upgrade
Issuance of Common Stock
0.440.4436.551.26215.63217.47
Upgrade
Repurchase of Common Stock
-0.07-0.19-0.57-0.58--
Upgrade
Other Financing Activities
---0.1612.31-0.96-3.23
Upgrade
Financing Cash Flow
0.370.2535.8212.99214.67323.1
Upgrade
Net Cash Flow
13.186.22-26.63-281.97315.947.76
Upgrade
Free Cash Flow
-85.96-90.96-60.14-111.25-97.78-75.66
Upgrade
Free Cash Flow Margin
-350.04%-457.29%-1018.66%---
Upgrade
Free Cash Flow Per Share
-1.29-1.36-0.93-1.91-1.74-2.78
Upgrade
Levered Free Cash Flow
-39.4-41.53-44.99-73.48-53.66-44.64
Upgrade
Unlevered Free Cash Flow
-39.4-41.53-44.99-73.48-53.66-44.64
Upgrade
Change in Net Working Capital
9.829.17-19.46.02-4.350.27
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q